Small But Increasingly Mighty: Latest Advances in AAV Vector Research, Design, and Evolution

衣壳 生物 计算生物学 转导(生物物理学) 载体(分子生物学) 腺相关病毒 基因组 病毒学 遗传学 基因 病毒 重组DNA 生物化学
作者
Dirk Grimm,Hildegard Büning
出处
期刊:Human Gene Therapy [Mary Ann Liebert, Inc.]
卷期号:28 (11): 1075-1086 被引量:105
标识
DOI:10.1089/hum.2017.172
摘要

Recombinant gene delivery vectors derived from naturally occurring or genetically engineered adeno-associated viruses (AAV) have taken center stage in human gene therapy, fueled by rapidly accumulating and highly encouraging clinical data. Nonetheless, it has also become evident that the current generation of AAV vectors will require improvements in transduction potency, antibody evasion, and cell specificity in order to realize their full potential and to widen applicability in larger patient cohorts. Fortunately, in the recent past, the field has seen a flurry of exciting new developments that enhance our understanding of AAV vector biology, including virus-host interactions, and/or that expand our arsenal of technologies for AAV capsid design and evolution. This review highlights a collection of latest advances in these areas, which, in the authors' opinion, hold particular promise to propel the AAV vector field forward in the near future, especially when applied in combination. These include fundamental novel insights into the AAV life cycle, from an unexpected role of autophagy and interactions with other viruses to the (re-)discovery of a universal AAV receptor and the function of AAV-AAP for capsid assembly. Concurrently, recent successes in the rational design of next-generation synthetic AAV capsids are pointed out, exemplified by the structure-guided derivation of AAV mutants displaying robust in vivo immune evasion. Finally, a variety of new and innovative strategies for high-throughput generation and screening of AAV capsid libraries are briefly reviewed, including Cre recombinase-based selection, ancestral AAV capsid reconstruction, and DNA barcoding of AAV genomes. All of these examples showcase the present momentum in the AAV field and, together with work by many other academic or industrial entities, raise substantial optimism that the remaining hurdles for human gene therapy with AAV vectors will (soon) be overcome.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小二郎应助聂雨声采纳,获得10
刚刚
刚刚
秋月明完成签到,获得积分10
刚刚
药叉完成签到,获得积分10
1秒前
李嗯呐发布了新的文献求助10
2秒前
2秒前
Gooselink应助罗春燕采纳,获得10
3秒前
破忒头应助liujinjin采纳,获得20
3秒前
4秒前
kenny完成签到,获得积分10
4秒前
陈熙发布了新的文献求助10
4秒前
hxy发布了新的文献求助10
4秒前
彭于晏应助小小彤采纳,获得10
4秒前
4秒前
cy发布了新的文献求助10
4秒前
4秒前
打打应助岁杪望舒采纳,获得10
5秒前
AAAA发布了新的文献求助10
5秒前
5秒前
吃了就会胖完成签到 ,获得积分10
5秒前
5秒前
星辰大海应助DJDJDDDJ采纳,获得10
6秒前
7秒前
7秒前
小蘑菇应助xuhang采纳,获得10
7秒前
7秒前
7秒前
大111完成签到,获得积分10
7秒前
阿饭完成签到,获得积分10
8秒前
9秒前
9秒前
9秒前
xieji发布了新的文献求助10
10秒前
丘比特应助愤怒的幻巧采纳,获得10
10秒前
10秒前
Jyhad完成签到 ,获得积分10
10秒前
飞0802发布了新的文献求助10
10秒前
11秒前
无限的寒珊完成签到,获得积分10
11秒前
怪奇物语发布了新的文献求助10
11秒前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
48V Low-voltage Power Distribution Network (PDN) Architecture Industry Report, 2024 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
Direct and Iterative Linear System Solvers 500
Plato's Parmenides. A Constructive Reading 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7302264
求助须知:如何正确求助?哪些是违规求助? 8920445
关于积分的说明 18895129
捐赠科研通 6966356
什么是DOI,文献DOI怎么找? 3211527
关于科研通互助平台的介绍 2380523
邀请新用户注册赠送积分活动 2188581